100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Treatment and prevention of Asthma : Abrofast-M Tablet PR is a combination of two medicines that can help prevent the onset of an asthma attack if it is taken before exercise or exposure to some �triggers�. These �triggers� may include house dust, pollen, pets, and cigarette smoke. This medicine relaxes the muscles of your airways which makes the air easier to get in and out. It will, therefore, allow you to exercise more freely without worrying about getting symptoms such as wheezing, coughing, and shortness of breath. This enables you to live your life more freely without worrying so much about things that set off your symptoms.In Treatment and prevention of Chronic obstructive pulmonary disease (COPD)Abrofast-M Tablet PR is a combination of two medicines that helps the airways in your lungs stay open. It works by relaxing the muscles of these airways. This makes it easier for air to get in and out. This medicine also loosens thick mucus, making it easier to cough out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing, and coughing and help you carry out your daily activities more easily. Abrofast-M Tablet PR usually starts to work within a few minutes and the effects can last up to several hours. Take it as prescribed by the doctor. Do not stop using it unless you are advised to by your doctor.In Treatment of Bronchitis Bronchitis leads to chest congestion and wheezing. Abrofast-M Tablet PR relieves symptoms of bronchitis by clearing congestion and relaxing airways. Take it for as long as the doctor has prescribed for maximum benefits.show moreshow less
Side effects of Abrofast-M Tablet PRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Abrofast-MVomiting Heartburn Stomach pain Rash Itching Hives Drowsiness Breathing problems Increased white blood cell count Nasal inflammation Flu-like symptoms Sinus infection Ear infection
How to use Abrofast-M Tablet PRUse it as advised by your doctor or check the label for directions before use. Abrofast-M Tablet PR can be taken it with or without food, although it's advisable to take it consistently at the same time.
How Abrofast-M Tablet PR works Abrofast-M Tablet PR is a combination of two medicines:Acebrophylline and montelukast. Acebrophylline is a mucolytic. It thins and loosens mucus (phlegm) making it easier to cough out. Montelukast is a leukotriene antagonist. It works by blocking the action of leukotriene, a chemical messenger. This reduces inflammation in the airways and nose to prevent asthma and relieve symptoms of allergies.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Abrofast-M Tablet PR .
Information regarding the use of Abrofast-M Tablet PR during pregnancy is not available. Doctor consultation is advised.
Information regarding the use of Abrofast-M Tablet PR during breastfeeding is not available. Doctor consultation is advised.
Abrofast-M Tablet PR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Abrofast-M Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Abrofast-M Tablet PR may be needed. Doctor consultation is advised.
Abrofast-M Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Abrofast-M Tablet PR may be needed. Doctor consultation is advised.
If a dose of Abrofast-M Tablet PR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
3 P.G. Street, Kolkata
Montelukast sodium. South Ruislip, Middlesex: Aurobindo Pharma - Milpharm Ltd.; 2012 (22 Apr. 2019)
Pozzi E. Acebrophylline: An airway mucoregulator and anti-inflammatory agent. Monaldi Arch Chest Dis. 2007;67(2):106-15 (01 Apr. 2019)
Montelukast. Whitehouse Station, New Jersey: Merck & Co., Inc.; 1998 (22 Apr. 2019)
PubChem. Acebrophylline (01 Apr. 2019)
Montelukast (12th Sept. 2023)
Pozzi E. Acebrophylline: an airway mucoregulator and anti-inflammatory agent. Monaldi Arch Chest Dis. 2007;67(2):106-15 (12th Sept. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.